Luna Laboratorysp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Suspended
Registry date
2016-11-28
Share capital
55 000,00 PLN
Activity description

Luna Laboratory is a Polish medical center based in Łódź that specializes in developing new technologies for the safe use of stem cells in the treatment of multiple sclerosis (MS). They offer a therapy that utilizes autologous stem cells derived from the patient's bone marrow, aiming to halt disease progression and alleviate various MS symptoms. Their unique technology ensures that only beneficial non-hematopoietic stem cells are administered, minimizing the risk of disease transmission and immune rejection.

Registered address
ul. Inwestycyjna 7, 95-050 Konstantynów Łódzki, Poland
Website
lunalab.plWebsite active
Email
Email warning

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Bank accounts

Registered as a VAT taxpayer on 2017-12-06. Active

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

6 public aid cases recorded, with a total value of $6,850.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,443
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,284
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,516

Tenders

No recorded participation in tenders.

Authorized Representatives

Wioletta Jadwiga Zdańska — President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations of will on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Andrzej Szczepan Wyrzykowski (75)
860$11,615.3478.1818%
Wioletta Jadwiga Zdańska (47)
229$3,092.9220.8182%
Others
11$148.571%

Beneficial owners

Person
Andrzej Szczepan Wyrzykowski (75)

Competitors

Name
Specjalistyczne Gabinetysp. z o.o.
NanosanguisS.A.
Oncotarget Wojciech JurczakS.K.A.
Sfpesp. z o.o.
Biostat Research And Developmentsp. z o.o.
Zawamedsp. z o.o.
Stenocoatsp. z o.o.
NanovelosS.A.
Medaisp. z o.o.
4cell TherapiesS.A.

Change history

DateEvent
2025-12-31Business suspended
2025-05-27Business resumed
2020-10-01Business suspended
2020-08-31Address change
2019-04-19Share capital change

FAQ

Last updated: 2026-07-15